09/21/2026
The KBI team has landed in Boston for this week! In addition to our three poster presentations, we’re thrilled to share an opportunity to hear from Sigma Mostafa, Chief Scientific & Technology Officer, on where the industry is headed – and how we’re preparing for it.
Join Sigma Mostafa’s presentation, “Evolving Cell Line Development for Next-Generation Biotherapeutics” on Thursday at 3:15 PM ET.
Summary: Advanced cell line development is critical to the success of biotherapeutic development, requiring high productivity, stability, and consistent performance from early stages through commercial manufacturing. In her presentation, Sigma will share information and case studies on TranspoEase™ and The Integration Paradigm Shift – including the improved expression of multi-chain proteins and future of targeted integration – and more information about the introduction, application, and benefits of ClearCHO™, The First VLP-Free CHO-M Cell Line.
Want to learn more? Stop by booth 505 to speak with our team! https://hubs.la/Q04x_fpP0 (https://hubs.la/Q04x_fmg0)